Mitochondrial DNA from osteoarthritic patients drives functional impairment of mitochondrial activity: a study on transmitochondrial cybrids

Cytotherapy. 2021 May;23(5):399-410. doi: 10.1016/j.jcyt.2020.08.010. Epub 2021 Mar 13.


With the redefinition of osteoarthritis (OA) and the understanding that the joint behaves as an organ, OA is now considered a systemic illness with a low grade of chronic inflammation. Mitochondrial dysfunction is well documented in OA and has the capacity to alter chondrocyte and synoviocyte function. Transmitochondrial cybrids are suggested as a useful cellular model to study mitochondrial biology in vitro, as they carry different mitochondrial variants with the same nuclear background. The aim of this work was to study mitochondrial and metabolic function of cybrids with mitochondrial DNA from healthy (N) and OA donors. In this work, the authors demonstrate that cybrids from OA patients behave differently from cybrids from N donors in several mitochondrial parameters. Furthermore, OA cybrids behave similarly to OA chondrocytes. These results enhance our understanding of the role of mitochondria in the degeneration process of OA and present cybrids as a useful model to study OA pathogenesis.

Keywords: chondrocytes; cybrids; metabolism; mitochondria; mtDNA; osteoarthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chondrocytes
  • DNA, Mitochondrial* / genetics
  • Humans
  • Mitochondria / genetics
  • Osteoarthritis* / genetics


  • DNA, Mitochondrial